enumaerate
发表于 2025-3-25 07:09:57
Conference proceedings 1997led consideration of thenovel cyclo-oxygenase-2 selective NSAIDs which have recently beendeveloped and introduced to the clinic. Also, the side effects fromtherapy with biologics, notably monoclonal antibodies and oraltolerance therapies, were considered. .Among the other highlights in the programme
Counteract
发表于 2025-3-25 10:45:37
http://reply.papertrans.cn/87/8670/866980/866980_22.png
CRANK
发表于 2025-3-25 14:48:42
http://image.papertrans.cn/s/image/866980.jpg
吹气
发表于 2025-3-25 19:00:51
https://doi.org/10.1007/978-94-011-5394-2joint; kidney; pharmacology; research; toxicity
诱拐
发表于 2025-3-25 22:05:33
978-94-010-6269-5Springer Science+Business Media Dordrecht 1997
GILD
发表于 2025-3-26 00:16:40
http://reply.papertrans.cn/87/8670/866980/866980_26.png
大酒杯
发表于 2025-3-26 07:32:38
http://reply.papertrans.cn/87/8670/866980/866980_27.png
abracadabra
发表于 2025-3-26 10:04:30
Summary of Debatetive of trying to reduce the occurrence of serious side-effects from these drugs, (b) where possible arrive at a . for recommending preventative procedures or treatments to reduce the side-effects from anti-rheumatic and analgesic agents, and (c) to make recommendations for future studies.
Arb853
发表于 2025-3-26 14:55:34
http://reply.papertrans.cn/87/8670/866980/866980_29.png
保守党
发表于 2025-3-26 16:50:52
http://reply.papertrans.cn/87/8670/866980/866980_30.png